lorazepam has been researched along with metoclopramide in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (28.57) | 18.7374 |
1990's | 32 (50.79) | 18.2507 |
2000's | 9 (14.29) | 29.6817 |
2010's | 4 (6.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fredrikson, M; Fürst, CJ; Hursti, T; Johansson, S; Peterson, C; Steineck, G | 2 |
Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E | 1 |
Gill, A; Marsh, M; Roberts, JT; Sands, R | 1 |
Cairns, V; Hilsenbeck, S; Hussein, AM; Sridhar, KS | 1 |
Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM | 1 |
Abad-Esteve, A; Barnadas, A; Carles, J; Moreno, I; Ribelles, N; Rosell, R | 1 |
Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC | 1 |
Artal, A; Chacón, JI; Feliu, J; García de Paredes, ML; García Girón, C; Garrido, P; González Barón, M; Herranz, C; Ordóñez Gallego, A; Zamora, P | 1 |
Advani, SH; Banavali, SD; Charak, BS; Gopal, R; Iyer, RS; Saikia, TK | 1 |
Francom, M | 1 |
Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH | 1 |
Azzolini, ME; Biondani, P; Capelli, MC; Grandinetti, A; Griso, C; Guglielmo, L; Martinelli, G; Martini, N; Molino, A; Zanotti, R | 1 |
Andersen, E; Hallas, J; Hannibal, J; Hansen, M; Herrstedt, J; Laursen, LC | 1 |
Guillén Lloveria, G; Mayordomo Cámara, JJ; Sáenz Cusi, A; Sáez Martínez, MJ; Tres Sánchez, A | 1 |
Aoki, Y; Horiuchi, Y; Kamikawa, R; Kyokane, K; Miwa, Y; Nagai, H; Ninomiya, E; Noro, T; Suga, S; Yasue, K | 1 |
Silvey, VL; Stephens, SH; Wheeler, RH | 1 |
Ballatori, E; Basurto, C; Bracarda, S; Del Favero, A; Picciafuoco, M; Roila, F; Tonato, M | 1 |
Navari, RM | 1 |
Kerr, S; Marshall, G; O'Gorman-Hughes, D; Vowels, M; White, L | 1 |
Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C | 1 |
Anderson, H; Barber, PV; Barnes, P; Cerny, T; Deiraniya, A; Stout, R; Thatcher, N; Wolstenholme, RJ | 1 |
Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A | 1 |
Davis, MP; Enck, RE; Furste, AB; Gutterman, L; Pritchard, JD; Wheeler, W | 1 |
Fujieda, K; Ibe, Y; Ito, T; Morinari, H; Naito, S; Okubo, S | 1 |
Colls, BM; Palmer, MC | 1 |
Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB | 1 |
Ackland, S; Bishop, JF; Cooper, IA; Hillcoat, BL; Matthews, JP; Morton, C; Scott, K; Wolf, M; Yuen, K | 1 |
de Wit, R; Veenhof, CH | 1 |
Capizzi, RL; Craig, JB; Powell, BL; White, DR | 1 |
Arai, R; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, T; Kodama, N; Tsuruta, S | 1 |
Clark, RA; Fiore, JJ; Gralla, RJ; Groshen, S; Kelsen, DP; Kris, MG; Tyson, LB | 1 |
Czarnetzki, BM; Kolde, G | 1 |
Cotanch, P; Laszlo, J; Stoudemire, A | 1 |
Gagen, M; Gaginella, T; Gochnour, D; Neidhart, J; Young, D | 1 |
Bolton, JA; Bowcock, SJ; Kang, AA; Retsas, S; Stockdale, AD | 1 |
Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG | 1 |
Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M | 1 |
Bishop, JF; Matthews, JP; Olver, IN; Smith, RA | 1 |
Allen, LV; Holland, JS; Prince, SJ; Stiles, ML | 1 |
Autier, P; Bleiberg, H; Michaux, D | 1 |
Agarwal, N; Misra, R | 1 |
Fanning, J; Hilgers, RD | 1 |
Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB | 1 |
Kilgore, JR; Navari, RM; Perrine, GM; Province, WS | 1 |
Bertetto, O; Cardinali, C; Clerico, M; Giaccone, G; Morandini, MP | 1 |
Barrett, RJ; Hahne, WF; Heck, K; Homesley, HD; Lentz, SS; Lovelace, JV; McLees, B; Woodlief, L | 1 |
Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G | 1 |
Crombez, R; Cunningham, D; de Mulder, P; Dicato, M; du Bois, A; McQuade, B; McRae, J; Parideans, R; Selby, P; Smyth, J; Stewart, A; van Straelen, D; Verweij, J | 1 |
Ichihara, S; Ichihara, T; Iwase, H; Kusugami, K; Nishio, Y; Saito, H; Shimada, M; Suga, S | 1 |
Chareoniam, V; Isariyodom, P; Manusirivithaya, S; Sungsab, D | 1 |
Arnold, RM; Buss, MK | 1 |
Weschules, DJ | 1 |
Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K | 1 |
4 review(s) available for lorazepam and metoclopramide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The treatment of vomiting caused by the administration of cytostatic agents].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Lorazepam; Metoclopramide; Vomiting | 1986 |
Recent advances in the pharmacologic and behavioral management of chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Behavior Therapy; Biofeedback, Psychology; Butyrophenones; Cannabinoids; Humans; Lorazepam; Metoclopramide; Nausea; Phenothiazines; Steroids | 1984 |
Cost-effectiveness analysis of antiemetic treatment.
Topics: Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Europe; European Union; Humans; Lorazepam; Metoclopramide; Ondansetron; Randomized Controlled Trials as Topic; Salvage Therapy; Serotonin Antagonists; Vomiting | 1994 |
38 trial(s) available for lorazepam and metoclopramide
Article | Year |
---|---|
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
Topics: Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Indoles; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Tropisetron; Vomiting | 1992 |
Five-drug antiemetic combination for cisplatin chemotherapy.
Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Droperidol; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged | 1992 |
Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
Topics: Antiemetics; Cisplatin; Dexamethasone; Humans; Lorazepam; Metoclopramide; Nausea; Prospective Studies; Pyrrolidines; Time Factors; Vomiting | 1991 |
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Biperiden; Cisplatin; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Humans; Imidazoles; Lorazepam; Melphalan; Metoclopramide; Middle Aged; Ondansetron; Ovarian Neoplasms; Vomiting | 1991 |
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
Topics: Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Vomiting | 1991 |
Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Leukemia, Myeloid, Acute; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1991 |
Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
Topics: Adult; Aged; Carboplatin; Cinnarizine; Cisplatin; Combined Modality Therapy; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Vomiting | 1991 |
The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Prospective Studies; Pyrrolidines; Vomiting | 1991 |
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Droperidol; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Vomiting | 1991 |
[Antiemetic treatments associated with antineoplastic chemotherapy].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lorazepam; Methylprednisolone; Metoclopramide; Vincristine; Vomiting | 1990 |
A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Evaluation; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Randomized Controlled Trials as Topic; Vomiting | 1990 |
Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Lung Neoplasms; Metoclopramide; Middle Aged; Nausea; Random Allocation | 1989 |
Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Topics: Adolescent; Antineoplastic Agents; Benztropine; Child; Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Random Allocation; Sleep Stages; Tropanes; Vomiting | 1989 |
The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1989 |
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
Topics: Adult; Aged; Amnesia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1989 |
A pilot study comparing decadron (D)/ativan (A) versus reglan (R)/decadron (D)/benadryl (B) as antiemetic regimens.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Neoplasms | 1988 |
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Random Allocation; Vomiting | 1987 |
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combination; Humans; Lorazepam; Male; Memory; Metoclopramide; Middle Aged; Random Allocation; Vomiting | 1987 |
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Prochlorperazine; Random Allocation; Vomiting | 1987 |
[The treatment of vomiting caused by the administration of cytostatic agents].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Lorazepam; Metoclopramide; Vomiting | 1986 |
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Time Factors; Vomiting | 1987 |
[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy].
Topics: Aged; Cisplatin; Dexamethasone; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Nausea; Random Allocation; Vomiting | 1987 |
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Nausea; Patient Compliance; Surveys and Questionnaires; Vomiting | 1985 |
[High-dosage metoclopramide versus lorazepam in cytostatic-induced gastrointestinal side effects].
Topics: Anti-Anxiety Agents; Dacarbazine; Gastrointestinal Diseases; Humans; Lorazepam; Metoclopramide | 1983 |
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Humans; Lorazepam; Metoclopramide; Middle Aged; Neoplasms; Random Allocation; Vomiting | 1984 |
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1984 |
Granisetron in the prevention of irradiation-induced emesis.
Topics: Adult; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Humans; Lorazepam; Male; Metoclopramide; Vomiting; Whole-Body Irradiation | 1995 |
Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
Topics: Adult; Cisplatin; Clemastine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Prospective Studies; Treatment Outcome; Vomiting | 1995 |
The roles of patient and observer assessments in anti-emetic trials.
Topics: Cross-Over Studies; Double-Blind Method; Humans; Lorazepam; Metoclopramide; Nurses; Observer Variation; Patients; Prochlorperazine; Time Factors; Treatment Outcome; Vomiting | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lorazepam; Metoclopramide; Ondansetron; Ovarian Neoplasms; Prochlorperazine; Severity of Illness Index; Single-Blind Method; Treatment Failure; Vomiting | 1994 |
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Ondansetron; Vomiting | 1994 |
Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
Topics: Adult; Aged; Antiemetics; Cisplatin; Costs and Cost Analysis; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron | 1993 |
Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methylprednisolone; Metoclopramide; Middle Aged; Neoplasms; Vomiting | 1993 |
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
Topics: Adult; Aged; Antiemetics; Cisplatin; Diphenhydramine; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; Pilot Projects; Serotonin Antagonists; Tropanes; Vomiting | 1993 |
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Clinical Protocols; Cyclophosphamide; Diphenhydramine; Double-Blind Method; Dronabinol; Female; Humans; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Placebos; Prochlorperazine; Transplantation, Autologous; Vomiting | 1995 |
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.
Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Europe; Female; Humans; Incidence; Lorazepam; Male; Metoclopramide; Middle Aged; Ondansetron | 1996 |
Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Diuresis; Drug Administration Schedule; Female; Gastrectomy; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil; Vomiting | 1996 |
Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chi-Square Distribution; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Ondansetron; Ovarian Neoplasms; Treatment Outcome; Vomiting | 2001 |
22 other study(ies) available for lorazepam and metoclopramide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Control of cisplatin induced emesis--a multidisciplinary intervention strategy.
Topics: Adult; Aged; Biperiden; Cisplatin; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; Oncology Nursing; Ovarian Neoplasms; Quality of Life; Vomiting | 1992 |
Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Cost-Benefit Analysis; Dexamethasone; Female; Humans; Imidazoles; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lorazepam; Metoclopramide; Nausea; Prochlorperazine; Time Factors; Vomiting | 1991 |
[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Vomiting | 1991 |
Compounding nausea aid.
Topics: Benztropine; Chemistry, Pharmaceutical; Dexamethasone; Diphenhydramine; Drug Combinations; Drug Compounding; Haloperidol; Humans; Lorazepam; Metoclopramide; Nausea; Suppositories; Vomiting | 1991 |
[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Infusions, Intravenous; Lorazepam; Metoclopramide; Nausea; Stomach Neoplasms; Tegafur; Uracil; Vomiting | 1990 |
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diphenhydramine; Drug Evaluation; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pilot Projects; Urinary Bladder Neoplasms; Vomiting | 1990 |
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Evaluation Studies as Topic; Female; Humans; Ifosfamide; Lorazepam; Lung Neoplasms; Male; Mesna; Metoclopramide; Middle Aged | 1987 |
[Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Mitomycin; Mitomycins; Vindesine; Vomiting, Anticipatory | 1988 |
Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
Topics: Antiemetics; Chromatography, High Pressure Liquid; Dexamethasone; Diphenhydramine; Drug Incompatibility; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusion Pumps; Lorazepam; Metoclopramide; Spectrophotometry, Ultraviolet; Temperature | 1994 |
Effective control of cisplatin induced emesis by combination drug regimen.
Topics: Adult; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; Ovarian Neoplasms; Remission Induction; Vomiting | 1994 |
Challenges in palliative care research: one experience.
Topics: Antiemetics; Attitude of Health Personnel; Diphenhydramine; Drug Combinations; Ethics Committees, Research; Haloperidol; Hospice Care; Humans; Lorazepam; Metoclopramide; Nausea; Palliative Care; Patient Selection; Randomized Controlled Trials as Topic | 2004 |
Tolerability of the compound ABHR in hospice patients.
Topics: Aged; Antiemetics; Cohort Studies; Diphenhydramine; Drug Combinations; Female; Haloperidol; Hospice Care; Humans; Lorazepam; Male; Metoclopramide; Nausea; Retrospective Studies; United States; Vomiting | 2005 |
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Prospective Studies; Surveys and Questionnaires; Vomiting | 2016 |